Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07213531Recruiting

Enhanced Valves Interventions and Safe AI Generated End Results

Role: collaborator

NCT04148703Not ApplicableUnknown

Cost-utility Analysis of the Follow-up of Exclusive Telemedicine Pacemakers, Compared to Conventional Pacemakers

Role: collaborator

NCT03571542Not ApplicableUnknown

Evaluation of the Respiratory Function in Renal Transplanted Children

Role: collaborator

NCT04584190Unknown

Real Life Use of Omalizumab in Chronic Urticaria

Role: collaborator

All 4 trials loaded